Introduction: France Biotech & LES France (Mathieu Losguardi (Temisis) & Frédéric Portal (Bird & Bird)

- Roundtable 1 - Partnership agreements: a tool for HealthTech companies to accelerate strategic development

o Sophie Binay; General Manager and Scientific Director at Acticor Biotech

o Cyrille Chapon; Director of Technology Transfer at Ouest Valorisation

o Aurélie Grienenberger; Chief Business Officer at Eligo Biosciences

o Moderator: Mathieu Losguardi; CEO Temisis Therapeutics

- Roundtable 2 – IP valuation : valuation and financial structuring

o Véronique Blum; President at AMAVI

o Caroline de Mareuil-Villette; Founding Partner at Icosa

o Moderator: Frédéric Portal; Lawyer, Counsel at Bird & Bird

- Roundtable 3 - Due diligence: key topics, best practices and pitfalls to avoid in IP

o Antonio Borderia, Executive Vice President Business Development at Adlin Science

o Mehdi Chelbi, CEO and co-founder of BiPER Therapeutics

o Emmanuelle Trombe, Attorney, Partner at McDermott Will & Emery

o Moderator: Matthieu Lebrun, Head of Global Out-Licensing Activities at Sanofi